RPID Stock Analysis: Buy, Sell, or Hold?
RPID - Rapid Micro Biosystems, Inc. Class A Common Stock
$2.07
0.06 (2.99%)
▲
5d:
+18.97%
30d:
+10.11%
90d:
-2.82%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When RPID Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: RPID is 7.8% above its trading range ($1.92). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: RPID is 7.8% above its trading range ($1.92). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: RPID is currently trading at $2.07, which is considered extended relative to its 30-day fair value range of $1.67 to $1.92.
Technical Outlook: Technically, RPID is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.17.
Market Sentiment: RPID has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.67 (+222.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RPID is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.17.
Market Sentiment: RPID has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.67 (+222.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.67 -
$1.92
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+7.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 222.1% below Wall St target ($6.67)
Trading Range Analysis
30-Day Trading Range
$1.67 -
$1.92
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$2.17
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.62
Wall Street Target
$6.67
(+222.1%)
Revenue Growth (YoY)
11.1%
Profit Margin
-145.8%
Share & Embed Analysis
Last updated: July 14, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPID showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Sean M Wirtjes
SELL
7480 shares
2026-03-11
John J Addington Wilson
SELL
9603 shares
2026-03-11
Robert G Jr. Spignesi
SELL
17922 shares
2026-03-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 50 HOLD |
